Marketed formulations of extended phenytoin sodium -- long a difficult medication to titrate because of its unique absorption and saturable elimination pharmacokinetics -- may not be bioequivalent ...

Pfizer and Flynn Pharma, manufacturers of phenytoin sodium capsules which are used to treat epilepsy, have been fined a combined total of £69 million by the Competitions Appeal Tribunal (CAT) for ...

This study evaluated the efficacy of intravenous sodium valproate to determine if it is non-inferior to intravenous phenytoin in SE treatment. Methods Patients diagnosed as SE during 2003–2010 ...

An appeal tribunal has upheld almost £70m in fines for two companies’ “illegal behaviour” that upped NHS spending on ...

In a judgment handed down on Wednesday, the U.K.’s Competition Appeal Tribunal found that Pfizer (PFE) and Flynn abused their dominant ...